Mikolaj Zmudzinski

9PUBLICATIONS
33CO-AUTHORS
Organometallic chemistryBiomolecular modelling and designMedical virologyProteins and peptidesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 29, 2026
SuFEx chemistry for nucleosides, nucleotides, and nucleic acids.

|Oct 15, 2025
Identification and Exploration of a Series of SARS-Cov‑2 M<sup>Pro</sup> Cyano-Based Inhibitors Revealing Ortho-Substitution Effects within the P3 Biphenyl Group.

Emma Clyde-Allen, Mikołaj Zmudzinski, Mohammad Afsar

|May 01, 2025
Proximity-induced SuFEx increases the potency of cytosolic nucleotidase inhibitors and reveals a rare example of covalently targeted histidine.

Mikolaj Chrominski, Marcin Warminski, Mateusz Kozarski

|May 01, 2023
SARS-CoV-2 M<sup>pro</sup> Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals.

Sizhu Amelia Chen, Elena Arutyunova, Jimmy Lu

|Nov 21, 2022
Amino acid variants of SARS-CoV-2 papain-like protease have impact on drug binding.

Agata P Perlinska, Adam Stasiulewicz, Mai Lan Nguyen

|Aug 28, 2021
<i>Reynoutria</i> Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors-Molecular Docking and In Vitro Study.

Izabela Nawrot-Hadzik, Mikolaj Zmudzinski, Adam Matkowski

Pageof 2

Frequent Collaborators

7 joint publications

Marcin Drag

4 joint publications

Wioletta Rut

2 joint publications

Digant Nayak

2 joint publications

Dirk Jochmans